mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice. Lee DW, Nasir A, Elbashir S, Jani H, et al. Vaccine 2025;54:126961.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee DW, Nasir A, Elbashir S, Jani H, et al. mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice. Vaccine 2025;54:126961.
PMID: 40056804